Alström Syndrome is an autosomal recessive disease characterized
by multiple organ involvement, including neurosensory vision and hearing loss,
childhood obesity, diabetes mellitus, cardiomyopathy, hypogonadism, and
pulmonary, hepatic, renal failure, and systemic fibrosis. Alström
Syndrome is caused by mutations in ALMS1, and ALMS1 protein is
thought to play a role in microtubule organization, intraflagellar transport,
endosome recycling and cell cycle regulation. Here, we report extensive
phenotypic and genetic analysis of a large cohort of Turkish patients with
Alström Syndrome. We evaluated 61 Turkish patients, including 11
previously reported, for both clinical spectrum and mutations in
ALMS1. To reveal the molecular diagnosis of the patients,
there different approaches were used in combination, a cohort of patients were
screened by the gene array to detect the common mutations in
ALMS1 gene, then in patients having any of common
ALMS1 mutations were subjected to direct DNA sequencing or
next generation sequencing for the screening of mutations in all coding regions
of the gene. In total, 20 distinct disease-causing nucleotide changes in
ALMS1 have been identified, 8 of which are novel, thereby
increasing the reported ALMS1 mutations by 6% (8/120).
Five disease-causing variants were identified in more than one kindred, but most
alleles were unique to each single patient and identified only once (16/20). So
far, 16 mutations identified were specific to the Turkish population, and four
have also been reported in other ethnicities. Additionally, 49 variants of
uncertain pathogenicity were noted, and four of these were very rare and
probably or likely deleterious according to in silico mutation
prediction analyses. Alström Syndrome has a relatively high incidence in
Turkey and the present study shows that the ALMS1 mutations are
largely heterogeneous; thus, these data from a particular population may provide
a unique source for the identification of additional mutations underlying
Alström Syndrome and contribute to genotype-phenotype correlation
studies.